Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06685783 · ClinicalTrials.gov registry record
Vis-Rx Prime Micro-Imaging Catheter Study
A clinical trial of Coronary Artery Disease, sponsored by Gentuity.
- Active
- Registry status
- 70
- Enrollment target
- 3
- Study locations
NCT06685783 is a study of Coronary Artery Disease that is active but no longer recruiting, run by Gentuity. The registered enrollment target is 70 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06685783, a study of Coronary Artery Disease, is active but no longer recruiting, sponsored by Gentuity.
- ACTIVE NOT RECRUITING
- Registry status
- 70 participants
- Enrollment target
- 3
- Study locations
Study Summary
To study the performance of the Gentuity® HF-OCT Imaging System and Vis-Rx Prime® Micro-Imaging Catheter when used to obtain images of coronary arteries in patients who are undergoing cardiac catheterization and are candidates for interventional procedures. The study will evaluate ease of catheter use by physicians using the catheters, image quality and overall performance. The patient's involvement in the study ends when the cardiac catheterization/interventional procedure is completed.
Conditions Studied
Study Locations (3)
Illinois
- Advocate Lutheran General Hospital - Park Ridge
New York
- St. Francis Hospital and Heart Center - Roslyn
Ohio
- Lindner Research Center at The Christ Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-12-11 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06685783
The ClinicalTrials.gov registry entry for NCT06685783 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (95% lower). The listed sponsor is Gentuity, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.
NCT06685783 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT06685783 about?
NCT06685783 is a clinical study titled "Vis-Rx Prime Micro-Imaging Catheter Study". To study the performance of the Gentuity® HF-OCT Imaging System and Vis-Rx Prime® Micro-Imaging Catheter when used to obtain images of coronary arteries in patients who are undergoing cardiac catheterization and are candidates for interventional procedures. The study will evaluate ease of catheter u...
What is the current status of trial NCT06685783?
This trial is currently active not recruiting. The enrollment target is 70 participants. The study started on 2024-12-11. Estimated completion is 2026-07.
What conditions does trial NCT06685783 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
Who is sponsoring clinical trial NCT06685783?
This trial is sponsored by Gentuity, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06685783 being conducted?
This trial has 3 study locations across Illinois, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.